Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: Results from the Studies of Left Ventricular Dysfunction (SOLVD)
- 15 November 1999
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 138 (5), 849-855
- https://doi.org/10.1016/s0002-8703(99)70009-8
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- National Patterns of Angiotensin-Converting Enzyme Inhibitor Use in Congestive Heart FailureArchives of Internal Medicine, 1997
- Heart Failure Treatment With Angiotensin-Converting Enzyme Inhibitors in Hospitalized Medicare Patients in 10 Large StatesArchives of Internal Medicine, 1997
- Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?International Journal of Cardiology, 1997
- Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)American Heart Journal, 1996
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Tolerability of enalapril initiation by patients with left ventricular dysfunction: Results of the medication challenge phase of the studies of left ventricular dysfunctionAmerican Heart Journal, 1994
- Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversibleJournal of Internal Medicine, 1992
- Safety of long-term use of lisinopril for congestive heart failureThe American Journal of Cardiology, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureThe New England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987